Suppr超能文献

12个月大女童患异位房性心动过速,接受伊伐布雷定和β受体阻滞剂治疗,病例报告

Ectopic Atrial Tachycardia in a 12-Month-Old Girl Treated With Ivabradine and Beta-Blocker, a Case Report.

作者信息

Michel Holger, Heißenhuber Frank, Wellmann Sven, Melter Michael, Gerling Stephan

机构信息

University Children's Hospital Regensburg (KUNO), University of Regensburg, Regensburg, Germany.

Clinic for Cardiology-Electrophysiology, Hospital Barmherzige Brüder, Regensburg, Germany.

出版信息

Front Pediatr. 2020 Jun 16;8:313. doi: 10.3389/fped.2020.00313. eCollection 2020.

Abstract

We report on a 12-month-old girl with an ectopic atrial tachycardia successfully treated with the combination of a beta blocking agent and Ivabradine that acts on cardiac pacemaker cells by selectively inhibiting the I channel. Standard therapy had failed to control the tachycardia before. No side effects attributable to Ivabradine were noticed. Due to its mechanism of action Ivabradine is a promising novel agent for the therapy of tachycardia due to increased automaticity. Reports on the use of Ivabradine in young children or infants are rare, but show promising results for congenital junctional ectopic tachycardia. This report adds the second case of ectopic atrial tachycardia in this age group and novel treatment with Ivabradine to the literature.

摘要

我们报告了一名12个月大的女孩,患有异位房性心动过速,通过β受体阻滞剂和伊伐布雷定联合治疗成功治愈,伊伐布雷定通过选择性抑制I通道作用于心脏起搏细胞。标准治疗此前未能控制心动过速。未观察到伊伐布雷定引起的副作用。由于其作用机制,伊伐布雷定是一种有前景的新型药物,可用于治疗因自律性增加导致的心动过速。关于伊伐布雷定在幼儿或婴儿中的应用报道很少,但对先天性交界性异位心动过速显示出有前景的结果。本报告为该年龄组异位房性心动过速的第二例病例及伊伐布雷定的新治疗方法增添了文献资料。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5609/7308433/95eedf35ef30/fped-08-00313-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验